Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04643964 · ClinicalTrials.gov registry record · NA

Brief Video Interventions for Depression

A NA study of Depressive Symptoms, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
655
Enrollment target
1
Study location

NCT04643964: Completed NA study of Depressive Symptoms, sponsored by Ohio State University.

NCT04643964 is a NA study of Depressive Symptoms that has completed, run by Ohio State University. The registered enrollment target is 655 participants, above the 251-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (161% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04643964, a NA study of Depressive Symptoms, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
655 participants
Enrollment target
1
Study location

Study Summary

In this study, we test brief video interventions for those with elevated depressive symptoms. We randomize participants to one of three conditions. (1) An entrée condition involving in-depth coverage a set of cognitive behavioral therapy (CBT) skills. (2) A sampler condition which introduces three sets of CBT skills. (3) A control condition involving no skills. Among those in the entrée condition, participants are further randomized to one of three CBT skills. We plan on two sets of primary comparisons. First, we will compare the effects of each form of video intervention (i.e., entrée and sampler) to the control condition. Second, we will compare the entrée and sampler conditions. We will recruit participants from Amazon's Mechanical Turk program (MTurk). In the intervention conditions, participants will be asked to watch several videos and practice skills using worksheets. They will also be asked to practice skills introduced in the videos in the week following the intervention. In the control condition, participants will not watch videos. One week after the intervention, all participants will respond to a follow-up assessment.

Primary Outcome

The Quick Inventory of Depressive Symptoms-Self Report is a 16-item self-report scale that measures depressive symptom severity. Scores range from 0 to 27, with higher scores indicating greater depressive symptoms.

Conditions Studied

Interventions

  • BEHAVIORAL Entrée: Cognitive skills
  • BEHAVIORAL Entrée: Behavioral skills
  • BEHAVIORAL Entrée: Interpersonal skills
  • BEHAVIORAL Sampler skills

Study Locations (1)

Ohio

  • Department of Psychology - Columbus

Trial Details

FieldValue
Enrollment Target 655 participants
Start Date 2020-11-17
Est. Completion 2021-06-05
Phase NA
Ohio State University

552 total trials

What the finished NCT04643964 record still lists

NCT04643964 is an interventional study that assigns participants to a tested intervention. The registered 655 participants enrollment target is mid-sized for trials with a published cap, above the 251-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (161% higher).

The record links to 1 condition, with Depressive Symptoms appearing as the primary indexed condition, and to 4 interventions - of which Entrée: Cognitive skills is the first listed.

NCT04643964 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04643964 about?

NCT04643964 is a clinical study titled "Brief Video Interventions for Depression". In this study, we test brief video interventions for those with elevated depressive symptoms. We randomize participants to one of three conditions. (1) An entrée condition involving in-depth coverage a set of cognitive behavioral therapy (CBT) skills. (2) A sampler condition which introduces three s...

What is the current status of trial NCT04643964?

This trial is currently completed. It is a NA study. The enrollment target is 655 participants. The study started on 2020-11-17. Estimated completion is 2021-06-05.

What conditions does trial NCT04643964 study?

This clinical trial studies the following conditions: Depressive Symptoms.

What interventions are being tested in trial NCT04643964?

The interventions under investigation include: Entrée: Cognitive skills (BEHAVIORAL), Entrée: Behavioral skills (BEHAVIORAL), Entrée: Interpersonal skills (BEHAVIORAL), Sampler skills (BEHAVIORAL).

Who is sponsoring clinical trial NCT04643964?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04643964 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depressive Symptoms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04643964's enrollment target sits among peer trials

655 3rd of 60 higher than 58 of 60 other Depressive Symptoms trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depressive Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07145515 · 655 participants · NA

    Enhancing Heart Allograft Function With the OCS Heart System Trial

  • NCT05407129 · 656 participants · NA

    Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences

  • NCT06127199 · 656 participants · NA

    Contraceptive Efficacy Study of Ovaprene

  • NCT03671044 · 657 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04643964, the US trial registry maintained by the National Library of Medicine. NCT04643964 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.